Alex howarth joins madrigal pharmaceuticals as chief financial officer

West conshohocken, pa., may 18, 2021 (globe newswire) -- madrigal pharmaceuticals, inc. (nasdaq:mdgl), a clinical-stage biopharmaceutical company pursuing novel therapeutics for cardio-metabolic and fatty liver diseases with high unmet medical need, announced today that alex howarth has joined madrigal as chief financial officer.
MDGL Ratings Summary
MDGL Quant Ranking